Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics - Bristol Myers Squibb

PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY, BMS) and Orbital Therapeutics (Orbital) today announced a definitive agreement under which BMS will acquire …